Literature DB >> 17402517

Types of crises in sickle cell disease patients presenting at the haematology day care unit (HDCU), University College Hospital (UCH), Ibadan.

J O Olabode1, W A Shokunbi.   

Abstract

OBJECTIVE: The aim of the study was to determine the types of crises in Sickle Cell Disease (SCD) patients seen at the Haematology Day Care Unit (HDCU) of the University College Hospital (UCH), Ibadan.
MATERIAL AND METHODS: The study is a retrospective survey using the registers of all patients seen in the year 2001 (January-December). Data extracted included demographic parameters, types of crises, haematocrit level and outcome of treatment received. The patients studied were both HbSS and HbSC in crises. RESULT: There were five hundred and eight HbSS and thirty seven HbSC patients seen during the survey period. Vaso-occlusive crisis had the highest prevalence of 91.6%, while haemolytic crisis had the least (0.5%). More females (56.7%) had crises than males (43.3%) in the vaso-occlusive group. The relationship between crises type and sex was not significant (p = 0.282). Young adults (20-29 years) had more crises (49.9%) than other age groups but crises were rare in children (0.2%). There was, however, a significant relationship between age group and crises type (p < 0.00). Eighty one percent of the subjects had PCV > 20%. The type of crisis is related significantly to the treatment received (p < 0.000). Fifty six percent of the subjects required analgesics alone while was admitted for blood transfusion and other medical, surgical, gynaecological and obstetric complications. There was only 1 (0.1%) recorded death within the 12 month survey period in a 31 year-old HbSC female who had painful and haemolytic crisis.
CONCLUSION: There were six types of crises seen in the sickle cell disease subjects namely vaso-occlusive, sequestration, infarctive, aplastic, haemolytic and bone pain crises. Vaso-occlusive crisis was the most common and haemolytic crises the least. Vaso-occlusive crisis was more common among young adults (20-29 year age group). The mortality rate was found to be 0.1%.

Entities:  

Mesh:

Year:  2006        PMID: 17402517

Source DB:  PubMed          Journal:  West Afr J Med        ISSN: 0189-160X


  7 in total

Review 1.  An Expert Review of Pharmacogenomics of Sickle Cell Disease Therapeutics: Not Yet Ready for Global Precision Medicine.

Authors:  Khuthala Mnika; Gift D Pule; Collet Dandara; Ambroise Wonkam
Journal:  OMICS       Date:  2016-09-16

2.  Mortality in sickle cell anemia in Africa: a prospective cohort study in Tanzania.

Authors:  Julie Makani; Sharon E Cox; Deogratius Soka; Albert N Komba; Julie Oruo; Hadija Mwamtemi; Pius Magesa; Stella Rwezaula; Elineema Meda; Josephine Mgaya; Brett Lowe; David Muturi; David J Roberts; Thomas N Williams; Kisali Pallangyo; Jesse Kitundu; Gregory Fegan; Fenella J Kirkham; Kevin Marsh; Charles R Newton
Journal:  PLoS One       Date:  2011-02-16       Impact factor: 3.240

Review 3.  Sickle cell disease: new opportunities and challenges in Africa.

Authors:  J Makani; S F Ofori-Acquah; O Nnodu; A Wonkam; K Ohene-Frempong
Journal:  ScientificWorldJournal       Date:  2013-09-19

4.  Subdissociative intranasal ketamine plus standard pain therapy versus standard pain therapy in the treatment of paediatric sickle cell disease vaso-occlusive crises in resource-limited settings: study protocol for a randomised controlled trial.

Authors:  James R Young; Hendry Robert Sawe; Juma A Mfinanga; Ernest Nshom; Ethan Helm; Charity G Moore; Michael S Runyon; Stacy L Reynolds
Journal:  BMJ Open       Date:  2017-07-10       Impact factor: 2.692

5.  "A child with sickle cell disease can't live with just anyone." A mixed methods study of socio-behavioral influences and severity of sickle cell disease in northern Nigeria.

Authors:  Zubairu Iliyasu; Awwal M Borodo; Binta W Jibir; Nafisa S Nass; Muktar H Aliyu
Journal:  Health Sci Rep       Date:  2020-12-23

Review 6.  Sickle cell disease and H3Africa: enhancing genomic research on cardiovascular diseases in African patients.

Authors:  Ambroise Wonkam; Julie Makani; Solomon Ofori-Aquah; Obiageli E Nnodu; Marsha Treadwell; Charmaine Royal; Kwaku Ohene-Frempong
Journal:  Cardiovasc J Afr       Date:  2015 Mar-Apr       Impact factor: 0.802

7.  Prescription audit in a paediatric sickle cell clinic in South-West Nigeria: A cross-sectional retrospective study.

Authors:  Fadare Joseph Olusesan; Olatunya Oladele Simeon; Ogundare Ezra Olatunde; Oluwayemi Isaac Oludare; Agaja Oyinkansola Tolulope
Journal:  Malawi Med J       Date:  2017-12       Impact factor: 0.875

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.